Abstract
CCN2 has been shown to be closely involved in the progression of renal fibrosis, indicating the potential of CCN2 inhibition as a therapeutic target. Although the examination of the phenotypes of adult CCN2 knockout mice with renal diseases has yielded valuable scientific insights, perinatal death has limited studies of CCN2 in vivo. Conditional knockout technology has become widely used for the deletion of genes in the desired cell populations and time points through the use of cell-specific Cre recombinase-expressing mice. Accordingly, several lines of CCN2 floxed mice have been developed for the assessment of the functional role of CCN2 in adult mice.
CCN2 levels are increased in renal fibrosis and proliferative glomerulonephritis, which represent good disease models for evaluating the effects of CCN2 deletion on the kidney. Of these, anti-glomerular basement membrane antibody glomerulonephritis has become the most widely used model for evaluating the effect of increased renal CCN2 expression. Herein, we describe the construction of CCN2 floxed mice and inducible systemic CCN2 conditional knockout mice and methods for the induction of anti-glomerular basement membrane antibody glomerulonephritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853–861
Yokoi H, Mukoyama M, Sugawara A et al (2002) Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 282:F933–F942
Kanemoto K, Usui J, Tomari S et al (2003) Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Invest 83:1615–1625
Duncan MR, Frazier KS, Abramson S et al (1999) Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 13:1774–1786
Yokoi H, Mukoyama M, Nagae T et al (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15:1430–1440
Guha M, Xu ZG, Tung D, Lanting L, Natarajan R (2007) Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 21:3355–3368
Adler SG, Schwartz S, Williams ME et al (2010) Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol 5:1420–1428
Falke LL, Dendooven A, Leeuwis JW et al (2012) Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney. Matrix Biol 31:421–431
Ivkovic S, Yoon BS, Popoff SN et al (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779–2791
Stricklett PK, Nelson RD, Kohan DE (1999) The Cre/loxP system and gene targeting in the kidney. Am J Physiol 276:F651–F657
Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP (1998) Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8:1323–1326
Feil R, Wagner J, Metzger D, Chambon P (1997) Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237:752–757
Liu S, Shi-wen X, Abraham DJ, Leask A (2011) CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 63:239–246
Pi L, Robinson PM, Jorgensen M et al (2015) Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice. Hepatology 61:678–691
Gibson DJ, Pi L, Sriram S et al (2014) Conditional knockout of CTGF affects corneal wound healing. Invest Ophthalmol Vis Sci 55:2062–2070
Liu S, Thompson K, Leask A (2014) CCN2 expression by fibroblasts is not required for cutaneous tissue repair. Wound Repair Regen 22:119–124
Fontes MS, Kessler EL, Stuijvenberg L et al (2015) CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload. J Mol Cell Cardiol 88:82–90
Suganami T, Mukoyama M, Sugawara A et al (2001) Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol 12:2652–2663
Nagashima T, Kim J, Li Q et al (2011) Connective tissue growth factor is required for normal follicle development and ovulation. Mol Endocrinol 25:1740–1759
Liu S, Leask A (2013) CCN2 modulates hair follicle cycling in mice. Mol Biol Cell 24:3939–3944
Liu S, Parapuram SK, Leask A (2013) Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2. Arthritis Rheum 65:2940–2944
Acknowledgments
This work was supported in part by research grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Japanese Ministry of Agriculture, Forestry, and Fisheries, the Japanese Ministry of Health, Labour, and Welfare, and Japan Agency for Medical Research and Development (AMED).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Toda, N., Yokoi, H., Mori, K., Mukoyama, M. (2017). Production and Analysis of Conditional KO Mice of CCN2 in Kidney. In: Takigawa, M. (eds) CCN Proteins. Methods in Molecular Biology, vol 1489. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6430-7_31
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6430-7_31
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6428-4
Online ISBN: 978-1-4939-6430-7
eBook Packages: Springer Protocols